Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud

NCT03027674 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Raynaud Phenomenon Due to Trauma
Raynaud Disease
System; Sclerosis
Lupus Erythematosus, Systemic
Dermatomyositis
Ultrasound Therapy; Complications

Interventions

DRUG: 10% nifedipine cream
DRUG: 5% sildenafil cream

Sponsor

Pontificia Universidad Catolica de Chile